Fish oil as a management component for mood disorders - An evolving signal

Current Opinion in Psychiatry

Volumn 26, Issue 1, 2013, Pages 33-40

  Hegarty, Bronwyn ^a,b   Parker, Gordon ^c  

^a PRINCE OF WALES HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Bipolar disorder; Depression; Fatty acids; Omega 3; Therapeutics

Indexed keywords

DOCOSAHEXAENOIC ACID; FISH OIL; ICOSAPENTAENOIC ACID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID;

DEPRESSION; DIET SUPPLEMENTATION; HUMAN; MOOD DISORDER; NONHUMAN; PREVALENCE; REVIEW;

DIETARY SUPPLEMENTS; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; FATTY ACIDS, OMEGA-3; FATTY ACIDS, OMEGA-6; FISH OILS; HUMANS; MOOD DISORDERS; NEUROPROTECTIVE AGENTS;

EID: 84870872947     PISSN: 09517367     EISSN: 14736578     Source Type: Journal    
DOI: 10.1097/YCO.0b013e32835ab4a7     Document Type: Review

References (90)

1. Parker G, Gibson NA, Brotchie H, et al. Omega-3 fatty acids and mood disorders. Am J Psychiatry 2006; 163:969-978.
2. Hibbeln JR. Fish consumption and major depression. Lancet 1998; 351:1213.
3. Hibbeln JR. Seafood consumption, the DHA content of mothers' milk and prevalence rates of postpartum depression: a cross-national, ecological analysis. J Affect Disord 2002; 69:15-29.
4. Noaghiul S, Hibbeln JR. Cross-national comparisons of seafood consumption and rates of bipolar disorders. Am J Psychiatry 2003; 160:2222-2227.
5. Hegarty BD, Parker GB. Marine omega-3 fatty acids and mood disorders: linking the sea and the soul. 'Food for Thought' I. Acta Psychiatr Scand 2011; 124:42-51.
6. Salem N, Litman B, Kim HY, Gawrisch K. Mechanisms of action of docosahexaenoic acid in the nervous system. Lipids 2001; 36:945-959.
7. Wall R, Ross RP, Fitzgerald GF, Stanton C. Fatty acids from fish: the antiinflammatory potential of long-chain omega-3 fatty acids. Nutr Rev 2010; 68:280-289.
8. Serhan CN, Chiang N, Van Dyke TE. Resolving inflammation: dual antiinflammatory and pro-resolution lipid mediators. Nat Rev Immunol 2008; 8:349-361.
9. Georgiadi A, Kersten S. Mechanisms of gene regulation by fatty acids. Adv Nutr 2012; 3:127-134.
10. Brenna JT. Animal studies of the functional consequences of suboptimal polyunsaturated fatty acid status during pregnancy, lactation and early postnatal life. Matern Child Nutr 2011; 7:59-79.
11. Chalon S. Omega-3 fatty acids and monoamine neurotransmission. Prostaglandins Leukot Essent Fatty Acids 2006; 75:259-269.
12. Rao JS, Ertley RN, Lee H-J, et al. n-3 polyunsaturated fatty acid deprivation in rats decreases frontal cortex BDNF via a p38 MAPK-dependent mechanism. Mol Psychiatry 2007; 12:36-46.
13. Numakawa T, Suzuki S, Kumamaru E, et al. BDNF function and intracellular signaling in neurons. Histol Histopathol 2010; 25:237-258.
14. Castrén E, Rantamäki T. The role of BDNF and its receptors in depression and antidepressant drug action: reactivation of developmental plasticity. Dev Neurobiol 2010; 70:289-297.
15. Sen S, Duman R, Sanacora G. Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications. Biol Psychiatry 2008; 64:527-532.
16. Grande I, Fries GR, Kunz M, Kapczinski F. The role of BDNF as a mediator of neuroplasticity in bipolar disorder. Psychiatry Investig 2010; 7:243.
17. Calder PC. Polyunsaturated fatty acids and inflammatory processes: new twists in an old tale. Biochimie 2009; 91:791-795.
18. Kiecolt-Glaser JK, Belury MA, Andridge R, et al. Omega-3 supplementation lowers inflammation and anxiety in medical students: a randomized controlled trial. Brain Behav Immun 2011; 25:1725-1734.
19. Kiecolt-Glaser JK, Belury MA, Andridge R, et al. Omega-3 supplementation lowers inflammation in healthy middle-aged and older adults: a randomized controlled trial. Brain Behav Immun 2012; 26:988-995.
20. Anisman H. Cascading effects of stressors and inflammatory immune system activation: implications for major depressive disorder. J Psychiatry Neurosci 2009; 34:4-20.
21. Maes M, Yirmyia R, Noraberg J, et al. The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression. Metab Brain Dis 2009; 24:27-53.
22. Dinan T, Siggins L, Scully P, et al. Investigating the inflammatory phenotype of major depression: focus on cytokines and polyunsaturated fatty acids. J Psychiatr Res 2009; 43:471-476.
23. Miller AH, Maletic V, Raison CL. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry 2009; 65:732-741.
24. Lu D-Y, Tsao Y-Y, Leung Y-M, Su K-P. Docosahexaenoic acid suppresses neuroinflammatory responses and induces heme oxygenase-1 expression in BV-2 microglia: implications of antidepressant effects for omega-3 fatty acids. Neuropsychopharmacol 2010; 35:2238-2248.
25. Eyre H, Baune BT. Neuroplastic changes in depression: a role for the immune system. Psychoneuroendocrinology 2012; 37:1397-1416.
26. Leonard B, Maes M. Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression. Neurosci Biobehav Rev 2012; 36:764-785.
27. Orr SK, Tré panier M-O, Bazinet RP. n-3 polyunsaturated fatty acids in animal models with neuroinflammation. Prostaglandins Leukot Essent Fatty Acids 2012. doi: 10.1016/j.plefa.2012.05.008. [Epub ahead of print]
28. McNamara RK, Jandacek R, Rider T, et al. Omega-3 fatty acid deficiency increases constitutive pro-inflammatory cytokine production in rats: relationship with central serotonin turnover. Prostaglandins Leukot Essent Fatty Acids 2010; 83:185-191.
29. Hennebelle M, Balasse L, Latour A, et al. Influence of omega-3 fatty acid status on the way rats adapt to chronic restraint stress. PLoS ONE 2012; 7:e42142.
30. Chen H-F, Su H-M. Exposure to a maternal n-3 fatty acid-deficient diet during brain development provokes excessive hypothalamic-pituitary-adrenal axis responses to stress and behavioral indices of depression and anxiety in male rat offspring later in life. J Nutr Biochem 2012. doi: 10.1016/j.jnutbio. 2012.02.006. [Epub ahead of print]
31. Moranis AL, Delpech J-C, De Smedt-Peyrusse V, et al. Long term adequate n-3 polyunsaturated fatty acid diet protects from depressive-like behavior but not from working memory disruption and brain cytokine expression in aged mice. Brain Behav Immun 2012; 26:721-731.
32. Mathieu G, Oualian C, Denis I, et al. Dietary n-3 polyunsaturated fatty acid deprivation together with early maternal separation increases anxiety and vulnerability to stress in adult rats. Prostaglandins Leukot Essent Fatty Acids 2011; 85:129-136.
33. Lafourcade M, Larrieu T, Mato S, et al. Nutritional omega-3 deficiency abolishes endocannabinoid-mediated neuronal functions. Nat Neurosci 2011; 14:345-350.
34. Borsonelo EC, Suchecki D, Galduróz JCF. Effect of fish oil and coconut fat supplementation on depressive-type behavior and corticosterone levels of prenatally stressed male rats. Brain Res 2011; 1385:144-150.
35. Ferraz AC, Delattre AM, Almendra RG, et al. Chronic v-3 fatty acids supplementation promotes beneficial effects on anxiety, cognitive and depressivelike behaviors in rats subjected to a restraint stress protocol. Behav Brain Res 2011; 219:116-122.
36. Vines A, Delattre AM, Lima MMS, et al. The role of 5-HT1A receptors in fish oilmediated increased BDNF expression in the rat hippocampus and cortex: a possible antidepressant mechanism. Neuropharmacol 2012; 62:184-191.
37. Park Y, Moon H-J, Kim S-H. N-3 polyunsaturated fatty acid consumption produces neurobiological effects associated with prevention of depression in rats after the forced swimming test. J Nutr Biochem 2012; 23:924-928.
38. Wietrzych-Schindler M, Szyszka-Niagolov M, Ohta K, et al. Retinoid X receptor gamma is implicated in docosahexaenoic acid modulation of despair behaviors and working memory in mice. Biol Psychiatry 2011; 69:788-794.
39. Jacka FN, Pasco JA, Mykletun A, et al. Association of Western and traditional diets with depression and anxiety in women. Am J Psychiatry 2010; 167:305-311.
40. Simopoulos AP. Evolutionary aspects of diet: the omega-6/omega-3 ratio and the brain. Mol Neurobiol 2011; 44:203-215.
41. Simopoulos AP. The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases. Exp Biol Med 2008; 233:674-688.
42. Harris WS, Mozaffarian D, Lefevre M, et al. Towards establishing dietary reference intakes for eicosapentaenoic and docosahexaenoic acids. J Nutr 2009; 139:804S-819S.
43. Meyer BJ, Mann NJ, Lewis JL, et al. Dietary intakes and food sources of omega-6 and omega-3 polyunsaturated fatty acids. Lipids 2003; 38:391-398.
44. Cordain L, Eaton SB, Brand Miller J, et al. Original Communications-The paradoxical nature of hunter-gatherer diets: meat-based, yet nonatherogenic. Eur J Clin Nutr 2002; 56:42.
45. Innis SM. Perinatal biochemistry and physiology of long-chain polyunsaturated fatty acids. J Pediatr 2003; 143:1-8.
46. Makrides M. Is there a dietary requirement for DHA in pregnancy? Prostaglandins Leukot Essent Fatty Acids 2009; 81:171-174.
47. Chatzi L, Melaki V, Sarri K, et al. Dietary patterns during pregnancy and the risk of postpartum depression: the mother-child 'Rhea' cohort in Crete, Greece. Public Health Nutr 2011; 14:1663-1670.
48. Murakami K, Sasaki S. Dietary intake and depressive symptoms: a systematic review of observational studies. Mol Nutr Food Res 2010; 54:471-488.
49. Kesse-Guyot E, Touvier M, Andreeva VA, et al. Cross-sectional but not longitudinal association between n-3 fatty acid intake and depressive symptoms: results from the SU.VI MAX 2 Study. Am J Epidemiol 2012; 175:979-987.
50. Lucas M, Mirzaei F, O'Reilly EJ, et al. Dietary intake of n-3 and n-6 fatty acids and the risk of clinical depression in women: a 10-y prospective follow-up study. Am J Clin Nutr 2011; 93:1337-1343.
51. Schacky von C. The omega-3 Index as a risk factor for cardiovascular diseases. Prostaglandins Other Lipid Mediat 2011; 96:94-98.
52. Sala-Vila A, Harris WS, Cofán M, et al. Determinants of the omega-3 index in a Mediterranean population at increased risk for CHD. Br J Nutr 2011; 106:425-431.
53. Peet M, Murphy B, Shay J, Horrobin D. Depletion of omega-3 fatty acid levels in red blood cell membranes of depressive patients. Biol Psychiatry 1998; 43:315-319.
54. Edwards R, Peet M, Shay J, Horrobin D. Omega-3 polyunsaturated fatty acid levels in the diet and in red blood cell membranes of depressed patients. J Affect Disord 1998; 48:149-155.
55. Lin P-Y, Huang SY, Su K-P. A meta-analytic review of polyunsaturated fatty acid compositions in patients with depression. Biol Psychiatry 2010; 68:140-147.
56. McNamara RK, Jandacek R, Rider T, et al. Selective deficits in erythrocyte docosahexaenoic acid composition in adult patients with bipolar disorder and major depressive disorder. J Affect Disord 2010; 126:303-311.
57. Pottala JV, Talley JA, Churchill SW, et al. Red blood cell fatty acids are associated with depression in a case-control study of adolescents. Prostaglandins Leukot Essent Fatty Acids 2012; 86:161-165.
58. Swenne I, Rosling A, Tengblad S, Vessby B. Omega-3 polyunsaturated essential fatty acids are associated with depression in adolescents with eating disorders and weight loss. Acta Paediatr 2011; 100:1610-1615.
59. Lewis MD, Hibbeln JR, Johnson JE, et al. Suicide deaths of active-duty US military and omega-3 fatty-acid status. J Clin Psychiatry 2011; 72:1585-1590.
60. Baghai TC, Varallo-Bedarida G, Born C, et al. Major depressive disorder is associated with cardiovascular risk factors and low omega-3 index. J Clin Psychiatry 2011; 72:1242-1247.
61. Jiang W, Oken H, Fiuzat M, et al. Plasma omega-3 polyunsaturated fatty acids and survival in patients with chronic heart failure and major depressive disorder. J Cardiovasc Transl Res 2012; 5:92-99.
62. Maes M, Ruckoanich P, Chang YS, et al. Multiple aberrations in shared inflammatory and oxidative & nitrosative stress (IO&NS) pathways explain the co-association of depression and cardiovascular disorder (CVD), and the increased risk for CVD and due mortality in depressed patients. Prog Neuropsychopharmacol Biol Psychiatry 2011; 35:769-783.
63. McNamara RK. DHA deficiency and prefrontal cortex neuropathology in recurrent affective disorders. J Nutr 2010; 140:864-868.
64. McNamara RK, Liu Y. Reduced expression of fatty acid biosynthesis genes in the prefrontal cortex of patients with major depressive disorder. J Affect Disord 2011; 129:359-363.
65. Hamazaki K, Hamazaki T, Inadera H. Fatty acid composition in the postmortem amygdala of patients with schizophrenia, bipolar disorder, and major depressive disorder. J Psychiatr Res 2012; 46:1024-1028.
66. Kraguljac NV, Montori VM, Pavuluri M, et al. Efficacy of omega-3 fatty acids in mood disorders-a systematic review and metaanalysis. Psychopharmacol Bull 2009; 42:39.
67. Martins JG. EPA but not DHA appears to be responsible for the efficacy of omega-3 long chain polyunsaturated fatty acid supplementation in depression: evidence from a meta-analysis of randomized controlled trials. J Am Coll Nutr 2009; 28:525-542.
68. Appleton KM, Rogers PJ, Ness AR. Updated systematic review and metaanalysis of the effects of n-3 long-chain polyunsaturated fatty acids on depressed mood. Am J Clin Nutr 2010; 91:757-770.
69. Bloch MH, Hannestad J. Omega-3 fatty acids for the treatment of depression: systematic review and meta-analysis. Mol Psychiatry 2011. doi: 10.1038/mp.2011.100. [Epub ahead of print]
70. Sublette ME, Ellis SP, Geant AL, Mann JJ. Meta-analysis of the effects of eicosapentaenoic acid (EPA) in clinical trials in depression. J Clin Psychiatry 2011; 72:1577-1584.
71. Martins JG, Bentsen H, Puri BK. Eicosapentaenoic acid appears to be the key omega-3 fatty acid component associated with efficacy in major depressive disorder: a critique of Bloch and Hannestad and updated meta-analysis. Mol Psychiatry 2012. doi:10.1038/mp.2012.25. [Epub ahead of print]
72. Lin P-Y, Mischoulon D, Freeman MP, et al. Are omega-3 fatty acids antidepressants or just mood-improving agents? The effect depends upon diagnosis, supplement preparation, and severity of depression.Mol Psychiatry 2012. doi:10.1038/mp.2012.111. [Epub ahead of print]
73. Bloch MH, Hannestad J. Response to critiques on 'Omega-3 fatty acids for the treatment of depression: systematic review and meta-analysis'. Mol Psychiatry 2012. doi:10.1038/mp.2012.116. [Epub ahead of print]
74. Ross BM, Seguin J, Sieswerda LE. Omega-3 fatty acids as treatments for mental illness: which disorder and which fatty acid? Lipids Health Dis 2007; 6:21.
75. Makrides M. Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial. JAMA 2010; 304:1675.
76. Gertsik L, Poland RE, Bresee C, Rapaport MH. Omega-3 fatty acid augmentation of citalopram treatment for patients with major depressive disorder. J Clin Psychopharmacol 2012; 32:61-64.
77. Tajalizadekhoob Y, Sharifi F, Fakhrzadeh H, et al. The effect of low-dose omega 3 fatty acids on the treatment of mild to moderate depression in the elderly: a double-blind, randomized, placebo-controlled study. Eur Arch Psychiatry Clin Neurosci 2011; 261:539-549.
78. Sinn N, Milte CM, Street SJ, et al. Effects of n-3 fatty acids, EPA v. DHA, on depressive symptoms, quality of life, memory and executive function in older adults with mild cognitive impairment: a 6-month randomised controlled trial. Br J Nutr 2011; 107:1682-1693.
79. Rondanelli M, Giacosa A, Opizzi A, et al. Long chain omega 3 polyunsaturated fatty acids supplementation in the treatment of elderly depression: effects on depressive symptoms, on phospholipids fatty acids profile and on healthrelated quality of life. J Nutr Health Aging 2011; 15:37-44.
80. Giltay EJ, Geleijnse JM, Kromhout D. Effects of n-3 fatty acids on depressive symptoms and dispositional optimism after myocardial infarction. Am J Clin Nutr 2011; 94:1442-1450.
81. Stoll AL, Severus WE, Freeman MP, et al. Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial. Arch Gen Psychiatry 1999; 56:407-412.
82. Chiu C-C, Huang S-Y, Chen C-C, Su K-P. Omega-3 fatty acids are more beneficial in the depressive phase than in the manic phase in patients with bipolar I disorder. J Clin Psychiatry 2005; 66:1613-1614.
83. Frangou S, Lewis M, McCrone P. Efficacy of ethyl-eicosapentaenoic acid in bipolar depression: randomised double-blind placebo-controlled study. Br J Psychiatry 2006; 188:46-50.
84. Keck PE Jr, Mintz J, McElroy SL, et al. Double-blind, randomized, placebocontrolled trials of ethyl-eicosapentanoate in the treatment of bipolar depression and rapid cycling bipolar disorder. Biol Psychiatry 2006; 60:1020-1022.
85. Sarris J, Mischoulon D, Schweitzer I. Omega-3 for bipolar disorder. J Clin Psychiatry 2011; 73:81-86.
86. Kinrys G. Hypomania associated with omega3 fatty acids. Arch Gen Psychiatry 2000; 57:715-716.
87. Rees A-M, Parker G. The role of fish oil in managing bipolar II disorder. In: Parker G, editor. Bipolar II Disorder. Modelling, Measuring and Managing, 2nd ed. Cambridge: Cambridge University Press; 2012. pp. 133-144.
88. Heart Foundation of Australia (2008). Fish, fish oils, n-3 polyunsaturated fatty acids and cardiovascular health. Position Statement. Downloaded from http://www.heartfoundation.org.au.
89. Nemets H, Nemets B, Apter A, et al. Omega-3 treatment of childhood depression: a controlled, double-blind pilot study. Am J Psychiatry 2006; 163:1098-1100.
90. Amminger GP, Schäfer MR, Papageorgiou K, et al. Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebocontrolled trial. Arch Gen Psychiatry 2010; 67:146-154.